Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, 10x Genomics Inc (NASDAQ: TXG) closed at $18.72 down -0.16% from its previous closing price of $18.75. In other words, the price has decreased by -$0.16 from its previous closing price. On the day, 1.43 million shares were traded. TXG stock price reached its highest trading level at $19.03 during the session, while it also had its lowest trading level at $18.45.
Ratios:
For a deeper understanding of 10x Genomics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.45 and its Current Ratio is at 5.22. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.11.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 22 ’24 when Saxonov Serge sold 4,877 shares for $24.30 per share. The transaction valued at 118,529 led to the insider holds 889,641 shares of the business.
Hindson Benjamin J. sold 4,087 shares of TXG for $99,329 on May 22 ’24. The insider now owns 350,055 shares after completing the transaction at $24.30 per share. On May 22 ’24, another insider, McAnear Justin J., who serves as the Chief Financial Officer of the company, sold 2,936 shares for $24.30 each. As a result, the insider received 71,355 and left with 146,203 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TXG now has a Market Capitalization of 2240933632 and an Enterprise Value of 1961303680. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.58 while its Price-to-Book (P/B) ratio in mrq is 3.12. Its current Enterprise Value per Revenue stands at 3.136 whereas that against EBITDA is -11.949.
Stock Price History:
Over the past 52 weeks, TXG has reached a high of $63.57, while it has fallen to a 52-week low of $18.39. The 50-Day Moving Average of the stock is -19.78%, while the 200-Day Moving Average is calculated to be -50.44%.
Shares Statistics:
For the past three months, TXG has traded an average of 1.63M shares per day and 1744600 over the past ten days. A total of 105.04M shares are outstanding, with a floating share count of 99.22M. Insiders hold about 17.11% of the company’s shares, while institutions hold 79.58% stake in the company. Shares short for TXG as of 1718323200 were 10479957 with a Short Ratio of 6.42, compared to 1715731200 on 10132248. Therefore, it implies a Short% of Shares Outstanding of 10479957 and a Short% of Float of 11.510000400000001.
